Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Mar 9, 2026, 6:57 PM EDT
Fate Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 46.63 | 36.06 | 41.87 | 61.33 | 133.58 | Upgrade
|
| Short-Term Investments | 157.03 | 243.01 | 273.31 | 374.89 | 482.33 | Upgrade
|
| Cash & Short-Term Investments | 203.66 | 279.07 | 315.18 | 436.23 | 615.91 | Upgrade
|
| Cash Growth | -27.02% | -11.46% | -27.75% | -29.17% | 27.54% | Upgrade
|
| Accounts Receivable | 0.92 | 3.54 | 1.83 | 38.48 | 8.68 | Upgrade
|
| Other Receivables | 0.7 | 2.1 | 0.9 | 0.8 | 1.1 | Upgrade
|
| Receivables | 1.62 | 5.64 | 2.73 | 39.28 | 9.78 | Upgrade
|
| Prepaid Expenses | 3.43 | 7.2 | 13.64 | 26.57 | 7.73 | Upgrade
|
| Total Current Assets | 208.7 | 291.91 | 331.54 | 502.07 | 633.41 | Upgrade
|
| Property, Plant & Equipment | 98.53 | 110.89 | 158.51 | 176.09 | 162.25 | Upgrade
|
| Long-Term Investments | 1.47 | 27.66 | 0.98 | 4.94 | 100.66 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 7.2 | 9.87 | Upgrade
|
| Other Long-Term Assets | 10.23 | 10.24 | 15.19 | 15.26 | 15.26 | Upgrade
|
| Total Assets | 318.94 | 440.69 | 506.22 | 705.56 | 921.46 | Upgrade
|
| Accounts Payable | 2.66 | 9.37 | 4.72 | 8.27 | 8.61 | Upgrade
|
| Accrued Expenses | 20.02 | 21.35 | 27.51 | 53.93 | 42.41 | Upgrade
|
| Current Portion of Leases | 4.56 | 7.42 | 6.18 | 5.63 | 5.58 | Upgrade
|
| Current Unearned Revenue | 0.38 | 0.39 | 0.69 | 42.23 | 21.48 | Upgrade
|
| Other Current Liabilities | 8.45 | - | - | 4 | 3.2 | Upgrade
|
| Total Current Liabilities | 36.07 | 38.52 | 39.09 | 114.05 | 81.28 | Upgrade
|
| Long-Term Leases | 73.29 | 77.85 | 97.36 | 103.71 | 109.24 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 27.12 | Upgrade
|
| Other Long-Term Liabilities | 2.4 | 5.6 | 1.35 | 3.86 | 24.97 | Upgrade
|
| Total Liabilities | 111.75 | 121.97 | 137.8 | 221.62 | 242.62 | Upgrade
|
| Common Stock | 0.12 | 0.11 | 0.1 | 0.1 | 0.1 | Upgrade
|
| Additional Paid-In Capital | 1,741 | 1,716 | 1,580 | 1,536 | 1,449 | Upgrade
|
| Retained Earnings | -1,534 | -1,398 | -1,212 | -1,051 | -769.08 | Upgrade
|
| Comprehensive Income & Other | 0.12 | 0.27 | 0.02 | -1.85 | -0.76 | Upgrade
|
| Total Common Equity | 207.18 | 318.72 | 368.41 | 483.94 | 678.84 | Upgrade
|
| Shareholders' Equity | 207.18 | 318.73 | 368.42 | 483.94 | 678.84 | Upgrade
|
| Total Liabilities & Equity | 318.94 | 440.69 | 506.22 | 705.56 | 921.46 | Upgrade
|
| Total Debt | 77.85 | 85.27 | 103.54 | 109.34 | 114.82 | Upgrade
|
| Net Cash (Debt) | 125.81 | 193.8 | 211.64 | 326.89 | 501.09 | Upgrade
|
| Net Cash Growth | -35.09% | -8.43% | -35.26% | -34.77% | 29.95% | Upgrade
|
| Net Cash Per Share | 1.06 | 1.70 | 2.15 | 3.38 | 5.29 | Upgrade
|
| Filing Date Shares Outstanding | 116.26 | 114.6 | 99.24 | 98.16 | 96.43 | Upgrade
|
| Total Common Shares Outstanding | 115.36 | 113.93 | 98.63 | 97.29 | 95.73 | Upgrade
|
| Working Capital | 172.63 | 253.39 | 292.45 | 388.02 | 552.13 | Upgrade
|
| Book Value Per Share | 1.80 | 2.80 | 3.74 | 4.97 | 7.09 | Upgrade
|
| Tangible Book Value | 207.18 | 318.72 | 368.41 | 483.94 | 678.84 | Upgrade
|
| Tangible Book Value Per Share | 1.80 | 2.80 | 3.74 | 4.97 | 7.09 | Upgrade
|
| Machinery | 29.61 | 38.85 | 83.29 | 81.5 | 53.63 | Upgrade
|
| Leasehold Improvements | 62.36 | 59.49 | 59.04 | 56.78 | 52.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.